# Celcuity Inc. Common Stock (CELC)

Celcuity Inc. will present at upcoming Stifel and Jefferies investor conferences, with CEO Brian Sullivan set to speak. This follows positive trial results for Gedatolisib and increased analyst price targets.

### About Celcuity Inc. Common Stock
Celcuity Inc. Common Stock (CELC) is a clinical-stage biotechnology company.  
Celcuity Inc. Common Stock uses the ticker $CELC for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Celcuity Inc. Common Stock (CELC) social dominance is up 636.67% from the previous week.

### Price: $104.50
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$celc/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$celc/time-series/close.tsv)  
The stock price has reached a 52-week and all-time high, driven by positive trial results for Gedatolisib, increased analyst price targets, and positive social media buzz, despite some mentions of market volatility.  

24-Hour: 1.95%
7-Day: -1.79%
30-Day: -2.29%

1-Year High: $117.30 on 2026-01-27  
1-Year Low: $8.20 on 2025-04-08  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$celc/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$celc/time-series/alt_rank.tsv)  
Celcuity Inc. Common Stock (CELC) is currently AltRank #1,538 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [-----] +355  
[--] Month: [-----] +893  
[--] Months: [-----] +1,414  
[--] Year: [-----] +310  
1-Year High: [-----] on 2026-02-09  
1-Year Low: [--] on 2025-12-28  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$celc/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$celc/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] [---]  
[--] Month: [--] [---]  
1-Year High: [--] on 2025-10-27  
1-Year Low: [--] on 2025-10-31  
  
  
### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$celc/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$celc/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [------]  
[--] Week: [-----] -59%  
[--] Month: [-------] -69%  
[--] Months: [---------] -12%  
[--] Year: [---------] +565%  
1-Year High: [-------] on 2025-07-28  
1-Year Low: [---] on 2025-05-03  

Engagements by network (24h):
News: [---]
Reddit: [--]
X: [---]
YouTube: [--]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$celc/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$celc/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [---]  
[--] Week: [---] -66%  
[--] Month: [-----] +140%  
[--] Months: [-----] +4.40%  
[--] Year: [-----] +1,435%  
1-Year High: [---] on 2025-07-30  
1-Year Low: [--] on 2025-05-10  

Mentions by network (24h):
News: [--]
Reddit: [--]
X: [--]
YouTube: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$celc/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$celc/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Celcuity Inc. Common Stock (CELC) in the last [--] hours which is down 14% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [---] -75%  
[--] Month: [---] +269%  
[--] Months: [-----] +42%  
[--] Year: [-----] +1,893%  
1-Year High: [---] on 2025-10-20  
1-Year Low: [--] on 2025-05-10  

The most influential creators that mention Celcuity Inc. Common Stock in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@seedy19tron](/creator/twitter/seedy19tron)         | [--]    | [------]    | [--]     | [--]          |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)           | [--]    | [------]    | [--]     | [--]          |
| [@avinash_redekar](/creator/twitter/avinash_redekar) | [--]    | [------]    | [--]     | [--]           |

[View More](/list/creators/$celc/100)
  
  
### Sentiment: 100%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$celc/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$celc/time-series/sentiment.tsv)  
Current Value: 100%  
Daily Average: 89%  
[--] Week: 100% no change  
[--] Month: 100% +7%  
[--] Months: 100% +18%  
[--] Year: 100% +50%  
1-Year High: 100% on 2025-02-18  
1-Year Low: 36% on 2025-09-17  

Most Supportive Themes:
- Upcoming Catalysts and Growth Potential: (35%) Posts highlighting upcoming catalysts and potential for growth in the biotech sector, specifically mentioning $CELC.
- Portfolio Updates and Trading Strategies: (30%) Posts mentioning $CELC alongside other stocks, often within the context of portfolio updates or trading strategies.
- Positive Company Reports and Gedatolisib Results: (20%) Posts highlighting positive company reports and strong results for $CELC, particularly regarding gedatolisib.
  
Most Critical Themes:
- Market Volatility and Price Action: (15%) Mentions of $CELC alongside other stocks in a volatile market, with some negative price action.
  
  
  
### Social Dominance: 0.00219%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$celc/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$celc/time-series/social_dominance.tsv)  
Current Value: 0.00219%  
Daily Average: 0.013%  
[--] Week: 0.00221% +0.00191%  
[--] Month: 0.0061% -0.0055%  
[--] Months: 0.0061% -0.021%  
[--] Year: 0.0061% +0.0025%  
1-Year High: 0.109% on 2025-07-29  
1-Year Low: 0.0015% on 2025-05-10  
  
  
### Market Dominance: 0.00548%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$celc/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$celc/time-series/market_dominance.tsv)  
Current Value: 0.00548%  
Daily Average: 0%  
1-Year High: 0.228% on 2026-02-06  
1-Year Low: 0.00548% on 2026-02-14  
  
  
### Market Cap: $4,835,809,278
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$celc/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$celc/time-series/market_cap.tsv)  
Current Value: $4,835,809,278  
Daily Average: $4,359,150,874  
[--] Week: $4,947,211,961 +0.19%  
[--] Month: $4,835,809,278 -0.73%  
1-Year High: $5,425,305,118 on 2026-01-27  
1-Year Low: $1,960,114,048 on 2025-10-14  

### Top Celcuity Inc. Common Stock News
Top news links shared on social in the last [--] hours  

*Showing a maximum of [--] news posts without a LunarCrush subscription.*  

"Celcuity Inc. To Present at Upcoming Stifel and Jefferies Investor Conferences MINNEAPOLIS Nov. [--] [----] (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) a clinical-stage biotechnology company pursuing development of targeted therapies for oncology today announced that Brian Sullivan Chief Executive Officer and Co-founder of Celcuity will present and be available for one-on-one investor meetings at the following investor conferences: A fireside chat at the Stifel [----] Healthcare Conference at 1:15 p.m. ET on Tuesday November [--] [----]. A live webcast will be availabl"  
[News Link](https://finance.yahoo.com/news/celcuity-inc-present-upcoming-stifel-120500476.html) [@YahooFinance](/creator/x/YahooFinance) 2024-11-12T12:05Z 228.6M followers, [---] engagements



### Top Celcuity Inc. Common Stock Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"Wolfe Research said in its $CELC (Outperform; PT $110) note: PersevERAing through an External Catalyst $RHHBY $RLAY AZN PFE NVS LLY Wolfe Research additionally said: We think investors should be careful when extrapolating giredestrant's prior success to persevERA as it is a more difficult trial to beat even after acknowledging that giredestrant is a good drug. We'd be buyers of CELC on any weakness related to the external catalyst. Leerink $CELC's PT to $118 from $97 and reiterated at an Outperform rating after Updating its Model Post-SABCS. $RHHBY $NVS AZN LLY PFE Leerink said in its note:"  
[X Link](https://x.com/Quantumup1/status/2019126083736531114) [@Quantumup1](/creator/x/Quantumup1) 2026-02-04T19:09Z [----] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing